Dear Website Visitor!
Please note that the following information may pertain to medicinal products. In accordance with the current legislation of the Russian Federation, access to such information is restricted to healthcare and pharmaceutical professionals only. By clicking "I Confirm," you certify that you are a qualified healthcare or pharmaceutical professional and accept full responsibility for any consequences arising from non-compliance with this restriction.
Leftofungin
- Trade name Leftofungin
- INN Caspofungin
- ATC Code [J02AX04]
- Marketing authorization number ЛП-008105
Description
First-line drug for the treatment of systemic mycoses, including in patients with risk factors. Possesses improved pharmacological properties, optimal clinical efficacy, and safety profile.
- Dosage
- Dosage form
- Quantity per package
- Solvent
- Quantity of solvent
- 70 mg
- Vial
- 10
- -
- -
- 70 mg
- Vial
- 5
- -
- -
- 70 mg
- Vial
- 1
- -
- -
- 50 mg
- Vial
- 10
- -
- -
- 50 mg
- Vial
- 5
- -
- -
- 50 mg
- Vial
- 1
- -
- -
